mortality/aging
• only a small number of mutants die before 12 months of age
|
growth/size/body
weight loss
(
J:108239
)
• some mutants show progressive weight loss by 12 months of age and beyond
|
cellular
• on average microtubule density is decreased by about 51% both in and outside of the nervous system at 20 to 26 weeks of age
|
behavior/neurological
• shortly after initial indications of neurological abnormalities, homozygous mutants in many cases can be distinguished by overall weakness compared to littermates
|
• shortly after initial indications of neurological abnormalities, homozygous mutants can be distinguished from littermates by bizarre limb positioning
|
• reduction in the amount of spontaneous movement is initial sign of abnormalities
|
• at 6-10 months of age, gait disturbances are detected in mutants
|
nervous system
• mutants show loss of myelinated and unmyelinated axons ranging in severity from 18-27% in the peripheral nerves by 9-12 months of age
• usually axons are enlarged, with pronounced axonal swelling
• at later stages, axons of mutants are marked by vesicular accumulation
|
• in mutants axons show degeneration with thin myeling sheath in both the peripheral and central nervous systems
|
• in axons from mutant mice, retrograde axonal transport is impaired
|
muscle
• at 12 months of age and beyond, some mutants display muscle wasting
|
muscle spasm
(
J:108239
)
• signs of spasticity are observed in some mutants shortly after initial indications of neurological abnormalities
|
• weakness starts from the hind limbs and progresses to the fore limbs
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
giant axonal neuropathy 1 | DOID:0090068 |
OMIM:256850 |
J:103926 , J:108239 |